Fanny Schmidt

The pharmacological profile of the thromboxane A2 antagonist BM 13.177. A new anti-platelet and anti-thrombotic drug

K. Stegmeier, J. Pill, B. Müller‐Beckmann et al. · Thrombosis Research · 1984 · 77 citations

Thrombopoiesis, Molecular Pharmacology, Thrombosis +13

Identification of VHY/Dusp15 as a Regulator of Oligodendrocyte Differentiation through a Systematic Genomics Approach

Fanny Schmidt, Monique van den Eijnden, Rosanna Pescini Gobert et al. · PLoS ONE · 2012 · 22 citations · Full text

Multiple Sclerosis Autopsies, Genetics, Immunology +23

Chemicals Possessing a Neurotrophin-Like Activity on Dopaminergic Neurons in Primary Culture

Fanny Schmidt, Pierre Champy, Blandine Séon‐Méniel et al. · PLoS ONE · 2009 · 20 citations · Full text

Effects of BM 15.766 on Serum Lipids in Rats

J. Pill, Fanny Schmidt, K. Stegmeier et al. · Hormone and Metabolic Research · 1985 · 20 citations

Lipid Analysis, Physiology, Lipid Science +2

Tryptamine-derived alkaloids from Annonaceae exerting neurotrophin-like properties on primary dopaminergic neurons

Fanny Schmidt, Gael Le Douaron, Pierre Champy et al. · Bioorganic & Medicinal Chemistry · 2010 · 19 citations

Primary Dopaminergic Neurons, Medicine, Neuropharmacology +8